إعلان
إعلان
APVO
Aptevo Therapeutics Inc
9.68
USDبرعاية
+0.48
+5.18%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
9.10
-0.57
-5.92%
تقارير أرباح APVO
النسبة الإيجابية المفاجئة
APVO تفوق 22 من 36 آخر التقديرات.
61%
التقرير التالي
بيانات التقرير القادم
١٢ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.45
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/-75.81%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/-99.97%
Aptevo Therapeutics Inc earnings per share and revenue
On ٠٦ نوفمبر ٢٠٢٥, APVO reported earnings of -1.86 USD per share (EPS) for Q3 25, beating the estimate of -2.13 USD, resulting in a 12.75% surprise. Revenue reached --, compared to an expected --, with a --% difference. The market reacted with a 0.00% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 المحللين forecast an EPS of -0.45 USD, with revenue projected to reach -- USD, implying an نقصان of -75.81% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were Aptevo Therapeutics Inc's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Aptevo Therapeutics Inc reported EPS of -$1.86, beating estimates by 12.75%, and revenue of $0.00, -- -- expectations.
How did the market react to Aptevo Therapeutics Inc's Q3 2025 earnings?
The stock price moved -- 0%, changed from $26.46 before the earnings release to $26.46 the day after.
When is Aptevo Therapeutics Inc expected to report next?
The next earning report is scheduled for ١٢ فبراير ٢٠٢٦.
What are the forecasts for Aptevo Therapeutics Inc's next earnings report?
Based on 3
المحللين, Aptevo Therapeutics Inc is expected to report EPS of -$0.45 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان